Galafold
Ended Awarded
- Contract number
- 36C26124N0645
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89 Part of Amicus Therapeutics, Inc.
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,089
Award facts
- Contract value 100% obligated
- $21,089.47 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Las Vegas, NV 89086, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Amicus Therapeutics US, LLC, a subsidiary of the publicly traded biopharmaceutical company Amicus Therapeutics, Inc. The contract is for the delivery of the specialty medication Galafold (migalastat), an approved enzyme replacement therapy used to treat Fabry disease, to VHA facilities and service networks nationwide.
The contract is issued under the General Services Administration (GSA) Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule, an indefinite-delivery, multiple-award vehicle. Amicus Therapeutics US, LLC has been awarded numerous delivery orders under this parent contract to supply Galafold capsules to specific VHA Integrated Service Networks, including VISN 5, VISN 7, VISN 9, and VISN 21. The contract has a potential value of $21,089.47 and a completion date of May 22, 2024. No set-aside designation has been applied to this contract.
Quick answers
Who was awarded contract 36C26124N0645?
36C26124N0645 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 21 (Veterans Health Administration) on May 8, 2024.
How much is contract 36C26124N0645 worth?
The government has obligated $21,089 on 36C26124N0645.
Is contract 36C26124N0645 an order under another contract?
Yes. 36C26124N0645 is a delivery order under 36F79719D0108, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0645 competed?
The extent of competition for 36C26124N0645 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award